Company Presentation • 07 Nov 2025 05:00
Company Presentation • 28 May 2025 19:00
Company Presentation • 01 Jun 2020 20:30
Company Presentation • 28 Sep 2021 20:30
Company Presentation • 30 Sep 2021 21:00
Search or
𝛼SK
𝛼SKENTITY
Altimmune (ALT US)
Altimmune (ALT US)
2
Analysis
Health Care • United States
Altimmune, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of novel peptide-based therapeutics for the treatment of obesity, NASH, chronic hepatitis B, and liver diseases. Altimmune serves patients and healthcare professionals worldwide.
morex